Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s00467-009-1322-7

http://scihub22266oqcxt.onion/10.1007/s00467-009-1322-7
suck pdf from google scholar
19908070!2887509!19908070
unlimited free pdf from europmc19908070    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid19908070      Pediatr+Nephrol 2010 ; 25 (8): 1409-18
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Membranoproliferative glomerulonephritis #MMPMID19908070
  • Alchi B; Jayne D
  • Pediatr Nephrol 2010[Aug]; 25 (8): 1409-18 PMID19908070show ga
  • Membranoproliferative glomerulonephritis is an uncommon kidney disorder characterized by mesangial cell proliferation and structural changes in glomerular capillary walls. It can be subdivided into idiopathic and secondary forms, which are differentially diagnosed by a review of clinical features, laboratory data, and renal histopathology. Three types-I, II, and III-have been defined by pathologic features. All three types are associated with hypocomplementemia, but they manifest somewhat different mechanisms of complement activation. Type II, also known as "dense deposit disease", is associated with the presence of C3-nephritic factor. Membranoproliferative glomerulonephritis primarily affects children and young adults, with patients presenting with nephrotic or nephritic syndrome or with asymptomatic renal disease. This type of glomerulonephritis often progresses slowly to end-stage renal disease, and it tends to recur after renal transplantation, especially type II. The efficacy of various forms of treatment remains controversial; however, long-term steroid treatment seems to be effective in children with nephrotic-range proteinuria. Improvement in renal outcomes largely relies on the evaluation of more selective agents in carefully controlled studies.
  • |Adult[MESH]
  • |Child[MESH]
  • |Complement Activation[MESH]
  • |Complement C3 Nephritic Factor[MESH]
  • |Glomerulonephritis, Membranoproliferative/diagnosis/*drug therapy/*pathology[MESH]
  • |Glomerulonephritis/pathology[MESH]
  • |Humans[MESH]
  • |Kidney Diseases/pathology[MESH]
  • |Kidney Failure, Chronic/pathology[MESH]
  • |Kidney Glomerulus/pathology[MESH]
  • |Kidney Transplantation[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box